DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Indegene Limited — Amalgamation OR Merger-XBRL

NSE 1 hr ago·10 Sept 2026, 2:26 pm

Indegene

Indegene Limited has informed stock exchanges that it is exploring a potential amalgamation or merger. This corporate action involves combining the company with another entity, which could result in the creation of a new, larger organization.

For investors, this development is significant as it signals a major strategic shift. A merger often aims to enhance operational efficiencies, expand market reach, or diversify business interests. The impact on Indegene's stock price will depend on the specific terms of the deal and the perceived value of the combined entity.

Investors should watch for official announcements regarding the target company and the valuation offered. The regulatory approval process and the integration strategy will also be critical factors to monitor in the coming weeks.